2.
RUNX1基因突变与预后核型及完全缓解的相关性
Correlation of RUNX1 mutations with prognostic karyotype and complete remission inAML patients
| Variable | Total | RUNX1mutated | RUNX1wildtype | P |
| Age (year) | 0.005 | |||
| ≥60 | 69 | 14 (20.28) | 55 (79.71) | |
| < 60 | 89 | 5 (5.62) | 84 (94.38) | |
| CR rate (140 analysis) | 71/140 (50.71) | 3/19 (15.79) | 68/121 (56.20) | 0.001 |
| Karyotype (152 analysis) | 0.198 | |||
| Normal | 75 | 12 (16.00) | 63 (84.00) | |
| Abnormal | 77 | 7 (9.09) | 70 (90.91) | |
| Cytogenetic risk group (152 analysis) | 0.069 | |||
| Favorable | 30 | 0 (0.00) | 30 (22.56) | |
| Intermediate | 72 | 11 (57.89) | 61 (45.86) | |
| Adverse | 50 | 8 (42.11) | 42 (31.58) |